Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 9;21(2):9.
doi: 10.1007/s11882-020-00985-7.

Asthma in Cystic Fibrosis: Definitions and Implications of This Overlap Syndrome

Chad R Marion  1   2 , Manuel Izquierdo  1 , Holly C Hanes  3 , Christopher Barrios  4
Affiliations
Review

Asthma in Cystic Fibrosis: Definitions and Implications of This Overlap Syndrome

Chad R Marion et al. Curr Allergy Asthma Rep. .

Abstract

Purpose of review: Cystic fibrosis (CF) is a multisystem, autosomal recessive disease that leads to progressive loss of lung function. Respiratory symptoms for both CF and asthma include cough, wheezing, and dyspnea. There is debate within the CF community on how to best define and distinguish CF-asthma overlap syndrome (CFAOS) from asthma-like features, though CFAOS is well-recognized. We aim to review the epidemiology, diagnosis, and treatment of asthma in CF and explore areas where further research is needed.

Recent findings: There has been considerable improvement in the understanding and treatment of asthma over the past two decades leading to novel therapies such as biologic agents that target the airway inflammation in asthmatics based on their asthma phenotype. These therapies are being studied in CFAOS and are promising treatments. This review provides a comprehensive overview of the definition, epidemiology, diagnosis, and current treatment of CFAOS.

Keywords: Asthma; Cystic fibrosis; Cystic fibrosis-asthma overlap syndrome.

PubMed Disclaimer

References

Papers of particular interest, published recently, have been highlighted as: • Of importance
    1. Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, et al. Diagnosis of cystic fibrosis: consensus guidelines from the Cystic Fibrosis Foundation. J Pediatr. 2017;181S:S4–S15.e1. https://doi.org/10.1016/j.jpeds.2016.09.064 . - DOI - PubMed
    1. Willis-Owen SAG, Cookson WOC, Moffatt MF. The genetics and genomics of asthma. Annu Rev Genomics Hum Genet. 2018;19:223–46. https://doi.org/10.1146/annurev-genom-083117-021651 . - DOI - PubMed
    1. Shrine N, Portelli MA, John C, Soler Artigas M, Bennett N, Hall R, et al. Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study. Lancet Respir Med. 2019;7(1):20–34. https://doi.org/10.1016/S2213-2600(18)30389-8 . - DOI - PubMed - PMC
    1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2020. Available from: www.ginasthma.org . (2020). Accessed.
    1. Ren CL, Konstan MW, Rosenfeld M, Pasta DJ, Millar SJ, Morgan WJ, et al. Early childhood wheezing is associated with lower lung function in cystic fibrosis. Pediatr Pulmonol. 2014;49(8):745–50. https://doi.org/10.1002/ppul.22894 . - DOI - PubMed